Previous 10 | Next 10 |
The U.S. Food and Drug Administration (FDA) approved Agilent Technologies' ( NYSE: A ) Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to Mirati Therapeutics ( NASDAQ: MRTX ) Krazati which was approved yesterday to treat certain patients with non-small cell ...
Agilent Technologies Inc. (NYSE: A) announced today that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatmen...
Moves up 28 places from 2022 Agilent Technologies Inc. (NYSE: A) today announced the company is ranked 101 in Newsweek’s 2023 list of America’s Most Responsible Companies , up 28 places from 2022. It marks Agilent’s fourth consecutive year on the prestigious list,...
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities Agilent Technologies Inc . (NYSE: A) today announced the opening of a new Customer Experience Center (CEC) in Lexington, MA, focused on solutions from Agilent genomics and diagnostics p...
Together with My Green Lab, Agilent is helping support customers in achieving their lab sustainability goals Agilent Technologies Inc. (NYSE: A) today announced that it has become the first ‘Angel’ level sponsor of My Green Lab, a nonprofit organization dedicated to building...
Innovative Insight200M liquid explosive detection system will further increase airport security and safety, and speed up passenger throughput Agilent Technologies Inc. (NYSE: A) today announced the deployment of the next generation of alarm resolution technology for checkpoi...
Outstanding fourth quarter caps off another strong year of performance in 2022 Fourth-quarter fiscal year 2022 Revenue of $1.85 billion represents 11% reported growth year-over-year; and up 17% on a core (1) basis. GAAP net income of $368 million with earnings per ...
Agilent Technologies ( NYSE: A ) declares $0.225/share quarterly dividend , 7.1% increase from prior dividend of $0.210. Forward yield 0.61% Payable Jan. 25; for shareholders of record Jan. 3; ex-div Dec. 30. See A Dividend Scorecard, Yield Chart, &a...
Agilent Technologies Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 22.5 cents per share of common stock, reflecting a 7% increase over the previous quarter. The quarterly dividend will be paid on January 25, 2023, to all shareholders of record as of ...
Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, president and chief executive officer, and Bob McMahon, chief financial officer, will present at the 5 th Annual Evercore ISI HealthCONx conference on Wednesday, November 30, at 10:50 a.m. PST. A live webcas...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...
Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2024 after the stock market closes on Aug. 21. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT. To join the listen-only conference call webcast,...